Your browser doesn't support javascript.
loading
Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.
Debbink, Kari; McCrone, John T; Petrie, Joshua G; Truscon, Rachel; Johnson, Emileigh; Mantlo, Emily K; Monto, Arnold S; Lauring, Adam S.
Afiliação
  • Debbink K; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
  • McCrone JT; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Petrie JG; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America.
  • Truscon R; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America.
  • Johnson E; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America.
  • Mantlo EK; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Monto AS; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America.
  • Lauring AS; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
PLoS Pathog ; 13(1): e1006194, 2017 01.
Article em En | MEDLINE | ID: mdl-28141862
While influenza virus diversity and antigenic drift have been well characterized on a global scale, the factors that influence the virus' rapid evolution within and between human hosts are less clear. Given the modest effectiveness of seasonal vaccination, vaccine-induced antibody responses could serve as a potent selective pressure for novel influenza variants at the individual or community level. We used next generation sequencing of patient-derived viruses from a randomized, placebo-controlled trial of vaccine efficacy to characterize the diversity of influenza A virus and to define the impact of vaccine-induced immunity on within-host populations. Importantly, this study design allowed us to isolate the impact of vaccination while still studying natural infection. We used pre-season hemagglutination inhibition and neuraminidase inhibition titers to quantify vaccine-induced immunity directly and to assess its impact on intrahost populations. We identified 166 cases of H3N2 influenza over 3 seasons and 5119 person-years. We obtained whole genome sequence data for 119 samples and used a stringent and empirically validated analysis pipeline to identify intrahost single nucleotide variants at ≥1% frequency. Phylogenetic analysis of consensus hemagglutinin and neuraminidase sequences showed no stratification by pre-season HAI and NAI titer, respectively. In our study population, we found that the vast majority of intrahost single nucleotide variants were rare and that very few were found in more than one individual. Most samples had fewer than 15 single nucleotide variants across the entire genome, and the level of diversity did not significantly vary with day of sampling, vaccination status, or pre-season antibody titer. Contrary to what has been suggested in experimental systems, our data indicate that seasonal influenza vaccination has little impact on intrahost diversity in natural infection and that vaccine-induced immunity may be only a minor contributor to antigenic drift at local scales.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Vacinas contra Influenza / Vacinação / Genoma Viral / Influenza Humana / Vírus da Influenza A Subtipo H3N2 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Vacinas contra Influenza / Vacinação / Genoma Viral / Influenza Humana / Vírus da Influenza A Subtipo H3N2 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article